MediGene AG (MDGEF.PK) Receives EUR 5 Million Milestone Payment From Astellas Pharma Inc. (YPH.BE)
5/7/2012 6:26:55 AM
More...
|
Quotient Announces New RapidFACT Program with MediGene AG (MDGEF.PK)
6/21/2011 9:29:10 AM
More...
|
MediGene AG (MDGEF.PK) and Johns Hopkins University Sign Development Collaboration for First Vaccine Candidates from MediGene's AAVLP Platform
5/31/2011 1:14:35 PM
More...
|
MediGene AG (MDGEF.PK) and Triton Pharma Sign Partnership Agreement for the Commercialization of Veregen(R) in Canada
4/19/2011 9:33:30 AM
More...
|
MediGene AG (MDGEF.PK) Announces Approval of Veregen(R) in Spain
3/30/2011 9:37:22 AM
More...
|
MediGene AG (MDGEF.PK) Reports on Fiscal Year 2010
3/25/2011 12:03:33 PM
More...
|
MediGene AG (MDGEF.PK) and Will-Pharma Sign Agreement for the Commercialization of Veregen(R) in Benelux
3/10/2011 10:33:49 AM
More...
|
MediGene AG (MDGEF.PK) Completes the Transfer of Eligard(R) Rights for EU Countries to Astellas Pharma Inc. (YPH.BE)
3/1/2011 11:30:40 AM
More...
|
MediGene AG (MDGEF.PK) and Pierre Fabre Sign Agreement for the Commercialization of Veregen(R) in Mexico, Central America, Venezuela and Colombia
2/22/2011 11:05:33 AM
More...
|
MediGene AG (MDGEF.PK) Concludes an Agreement with Laboratoires Expanscience for the Commercialization of Veregen(R) in France
1/13/2011 10:32:40 AM
More...
|
|